Compounds and methods for down-regulating Wrap53 protein by...

Details Compounds and methods for down-regulating Wrap53 protein by... Compounds and methods for down-regulating Wrap53 protein by...

2011-03-08

2011-03-08

Vivlemore, Tracy (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C536S024500

Reexamination Certificate

active

07902167

ABSTRACT:
A small nucleic acid molecule that down-regulates expression of Wrap53 gene via RNA interference (RNAi), wherein at least one strand of said small nucleic acid molecule is about 15 to about 30 nucleotides in length; and wherein at least one strand of said small nucleic acid molecule comprises a nucleotide sequence having sufficient complementarity to an RNA of said Wrap53 gene for the small nucleic acid molecule to direct cleavage of said RNA via RNA interference, for use as a medicament.

REFERENCES:
patent: 6943241 (2005-09-01), Isogai et al.
patent: 2006/0025361 (2006-02-01), McSwiggen et al.
patent: 2006/0035815 (2006-02-01), Chen et al.
patent: 2006/0063174 (2006-03-01), Turner et al.
patent: 2006/0069056 (2006-03-01), Feinstein et al.
patent: 2007/0104688 (2007-05-01), Rossi et al.
patent: 2009/0149377 (2009-06-01), Takagi et al.
patent: 93/23569 (1993-11-01), None
patent: 94/02595 (1994-02-01), None
patent: 99/04819 (1999-02-01), None
patent: 99/05094 (1999-02-01), None
patent: 2004097020 (2004-11-01), None
Mahmoudi et al. Molecular Cell 2009, vol. 33, pp. 462-471.
Lockshin and Zakeri, Programmed cell death and apoptosis:origins of the theory, Nat Rev Mol Cell Bio, (2) p. 545-50, 2001.
Velazquez-Fernandez et al., Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism (pHPT): primary parathyroid hyperplasia versus adenoma, World Journal of Surg, 30 (5):705-712, May 20, 2006; (XP-002489844).
Zhang, GEPIS-quantitative gene expression profiling in normal and cancer tissues, Bioinformatics, (20) p. 2390-8, 2004; (XP-002489845).
Fu, Roles of aurora kinases in mitosis and tumorigenesis, Mol Cancer Res, (5) p. 1-10, 2007.
Zamore et al., RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals, 2000, Cell, 101, 25-33.
Fire et al., Potent and specific genetic interference by double-stranded RNA inCaenorhabditis elegans, 1998, Nature, 391,806.
Sharp, RNAi and double-strand RNA, 1999, Genes & Dev., 13:139-141 .
Strauss, Molecular biology: Candidate ‘gene silencers’ found,1999, Science, 286, 886.
A. E. Pasquinelli et al., Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA, Nature 408, 86 (2000).
Scaringe et al, Novel RNA synthesis method using 5′-O-Silyl-2′-O-orthoester protecting groups, J. Am. Chem. Soc. 120:11820 (1998).
Song et al., RNA interference targeting FAS protects mice from fulminant hepatitis, Nat. Med, 2003, 9:347-351.
Li et al., Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque, Nat. Med, 2005, 11:944-951.
Quinlan, E. (2005) ARVO Annual Meeting, May 1-5, Ft Lauderdale, FL, USA.
Farnebo, Examensarbete, Internet Article, pp. 1-2 (2007).
Database uniProt, WD repeat-containing protein 79 (2001).

Affiliated with

Also associated with

Rating

Compounds and methods for down-regulating Wrap53 protein by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and methods for down-regulating Wrap53 protein by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for down-regulating Wrap53 protein by... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2778909